Clinical Trials

91 enrolled

Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT02035527 2018-05-24

Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Phase 1 Completed

3 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Salivary Gland Neoplasms, Tongue Neoplasms

NCT02088515 2017-03-03

Nedaplatin (Jiebaishu®) Combined With Docetaxel for Advanced Lung Squamous Cell Carcinoma

Phase 4 Completed

290 enrolled

Carcinoma, Squamous Cell

NCT01362400 2014-05-19

A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer

226 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms, Carcinoma, Large Cell

NCT01561456 2013-12-05

Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the Lung

100 enrolled

Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell

NCT00935961 2013-08-09

RAD001 (Everolimus) + Docetaxel + Cisplatin as Induction Chemotherapy in Patients With Local-Regional Advanced Head and Neck Cancer

Phase 1 Completed

18 enrolled

Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT00113347 2012-02-27

Erlotinib and Docetaxel With Concomitant Boost Radiation Therapy (XRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)

Phase 1 Completed

10 enrolled

Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT00432315 2010-09-14

Docetaxel in Non Small Cell Lung Cancer (NSCLC)

80 enrolled

Carcinoma, Squamous Cell

NCT00139243 2008-06-04

Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and Neck

Phase 1/2 Completed

30 enrolled

Carcinoma, Squamous Cell

NCT00139230 2008-06-03

Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck

30 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell

NCT00539630 2007-10-04

TAX + Cisplatin + 5 F/U vs Cisplatin + 5 F/U in SCCHN

Phase 3 Completed

86 enrolled